Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux
Conclusion: In patients with PPI-refractory GERD, VPZ provides more potent gastric acid suppression, more effective EAE control, enhanced symptom improvement, and better esophagitis healing than PPIs.Digestion
Source: Digestion - Category: Gastroenterology Source Type: research
More News: Acid Reflux | Erosive Esophagitis | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Potassium | Proton Pump Inhibitors PPIs | Study